Proven patency. Measurable value.
With more than a decade of strong performance that includes improving outcomes and reducing reinterventions this longstanding bypass graft helps deliver both proven clinical and economic value for patients and hospitals.
Reduce blood loss and time to hemostasis.
Improving grafting in peripheral, aortic, and vascular access procedures.
All the silicone based valves are designed and manufactured using polypropylene and silicone elastomer which decreases the possibility of deformation of the valves due to sticking.
Early cannulation. Immediate benefits for hemodialysis care..
